India Records 42,618 New COVID Cases

COVID cases in India have increased to 3,29,45,907 after 42,618 people tested positive for the virus in the last 24 hours, the latest Health Ministry data.

Meanwhile, a total of 330 fatalities were also reported in the same duration, which pushed the death toll to 4,40,225, as per the Ministry data.

COVID-19: Diet Plan and Lifestyle Modifications for the Unlock Phase
Healthy eating habits and adherence to physical activity are required during COVID-19 lockdown. WHO has prepared a set of general tips that you could follow during the lockdown to stay fit and healthy.

‘India's cumulative Covid-19 vaccination coverage has crossed 67 crore.’

Following a substantial growth of 5,903, the number of active cases currently stood at 4,05,681.

In the same period, a total of 36,385 Covid patients were discharged from hospitals and health centers across the country, pushing the overall recoveries to 3 21,00,001.

The recovery rate currently stands at 97.43 per cent.

Fluvoxamine: An OCD Drug can Prevent Covid-19 Patients from Hospitalization
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.

According to the Ministry data, while the weekly positivity rate is at 2.63 per cent, which has been less than 3 per cent for the last 71 days, the daily positivity rate is reported to be 2.50 per cent.

The daily positivity rate has remained below 5 per cent for 89 consecutive days now.

Green Fungus or Aspergillosis and COVID-19 Infection
Green fungus or Aspergillosis is caused by a common mold, which exists both indoors and outdoors. Every day, people inhale Aspergillus spores, but it isn't harmful. However, it affects people who have a weak immune system. If the infection is left untreated, it can cause pneumonia.

With the administration of 58,85,687 doses in the last 24 hours, India's vaccination coverage figure stands at 67,72,11,205 as per provisional reports of the Health Ministry.

This has been achieved through 70,88,424 sessions.

Mucormycosis (Black Fungal Disease): A Complication of COVID-19
Mucormycosis is spread by spores from the black fungus, Mycormycetes. It mainly affects people with a weak immune system and attacks the lungs and other organs of the body. It is also known as Black Fungal Disease.

The testing capacity across the country continues to be expanded.

The last 24 hours saw a total of 17,04,970 tests being conducted. India has so far conducted 52,82,40,038 tests.

Source-IANS